insulin resistance obesity hypertension and dyslipidemia are strongly associated with metabolic syndrome mesy which is considered to be a reversible clinical stage before its evolution to coronary heart disease and diabetescurrently the antihypertensive and hypolipidemic properties of aqueous hibiscus sabdariffa extracts hse have been demonstrated in clinical trials and in vivo experimentsthe aim of the present study was to evaluate the effects of a hibiscus sabdariffa extract powder hsep and a recognized preventive treatment diet on the lipid profiles of individuals with and without mesy according to the national cholesterol education program adult treatment panel iii ncepatp iii criteriathe protocol was a followup study carried out in a factorial randomized design t1preventive treatment comprises diet t2hsep t3hseppreventive treatment diet x mesy nonmesy individualsa total daily dose of 100 mg hsep was orally administered in capsules for one monththe preventive treatment diet was selected according to ncepatp iii recommendations and adjusted individuallytotal cholesterol ldlc hdlc vldlc triglycerides glucose urea creatinine ast and alt levels in the blood were determined in all individuals pre and posttreatmentthe mesy patients treated with hsep had significantly reduced glucose and total cholesterol levels increased hdlc levels and an improved taghdlc ratio a marker of insulin resistance ttest p005additionally a triglyceridelowering effect was observed in mesy patients treated with hsep plus diet and in individuals without mesy treated with hsepsignificant differences in total cholesterol hdlc and the taghdlc ratio were found when the means of absolute differences among treatments were compared anova p002therefore in addition to the well documented hypotensive effects of hibiscus sabdariffa we suggest the use of hsep in individuals with dyslipidemia associated with mesy